Lipolytic action of 3,3'5-triiodo-L-thyronine, a cyclic AMP phosphodiesterase inhibitor.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D004822:Epididymis; D005223:Fats / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors*; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology; D013970:Thyronines / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology*
D000227:Adenine Nucleotides; D005223:Fats; D007328:Insulin; D011453:Prostaglandins; D013565:Sympatholytics; D013970:Thyronines; D014284:Triiodothyronine; D010744:Phosphoric Monoester Hydrolases; D005990:Glycerol; D013974:Thyroxine; D009638:Norepinephrine